Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Breast Neoplasms, Male × Lapatinib × Clear all

Phase

Status

Sponsor Class

OTHER 7 NIH 5 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 6 Head and Neck Neoplasms 2 Waldenstrom Macroglobulinemia 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Invasive Breast Cancer 1 Inflammatory Breast Neoplasms 1 Immunoblastic Lymphadenopathy 1 Her2 Positive Metastatic Breast Cancer 1 Burkitt Lymphoma 1 Breast Neoplasms, Male 1

Interventions

Paclitaxel 3 Docetaxel 3 Watchful Waiting 2 Tamoxifen 2 Immunohistochemistry 2 Goserelin 2 Everolimus 2 Cyclophosphamide 2 Bevacizumab 2 Anastrozole 2 vandetanib 1 pegfilgrastim 1 lonafarnib 1 exemestane 1 Trastuzumab 1 Sunitinib 1 Psychiatric Rehabilitation 1 Neoadjuvant Therapy 1 Metformin 1 Mental Status and Dementia Tests 1 Leuprolide 1 Letrozole 1 Lapatinib 1 High-Energy Shock Waves 1 Gene Expression Profiling 1 Doxorubicin 1 Dasatinib 1 Chemotherapy, Adjuvant 1 Biopsy, Needle 1 Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00424164 2024-03-08

LAPATAM

European Organisation for Research and Treatment of Cancer - EORTC

Phase 1 Completed

Breast Neoplasms, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon ⚡